UH
LLY icon

Unigestion Holding’s Eli Lilly LLY Stock Holding History

Unigestion Holding’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$3.31M Buy
4,012
+2,459
+158% +$2.05M 0.19% 95
2024
Q4 		$1.2M Sell
1,553
-212
-12% -$176K 0.07% 106
2024
Q3 		$1.56M Sell
1,765
-450
-20% -$405K 0.08% 93
2024
Q2 		$1.29M Buy
2,215
+579
+35% +$463K 0.07% 97
2024
Q1 		$1.27M Sell
1,636
-579
-26% -$412K 0.06% 101
2023
Q4 		$1.29M Sell
2,215
-825
-27% -$482K 0.07% 97
2023
Q3 		$1.63M Sell
3,040
-832
-21% -$429K 0.1% 95
2023
Q2 		$1.8M Sell
3,872
-913
-19% -$383K 0.1% 99
2023
Q1 		$1.63M Sell
4,785
-1,197
-20% -$404K 0.09% 116
2022
Q4 		$2.2M Buy
5,982
+840
+16% +$298K 0.12% 109
2022
Q3 		$1.7M Buy
5,142
+217
+4% +$68.8K 0.1% 115
2022
Q2 		$1.6M Sell
4,925
-304
-6% -$91.3K 0.09% 108
2022
Q1 		$1.5M Sell
5,229
-2,371
-31% -$610K 0.06% 108
2021
Q4 		$2.1M Buy
7,600
+374
+5% +$94.8K 0.09% 97
2021
Q3 		$1.67M Buy
7,226
+6,035
+507% +$1.49M 0.07% 98
2021
Q2 		$273K Sell
1,191
-3,581
-75% -$719K 0.01% 221
2021
Q1 		$892K Sell
4,772
-12,261
-72% -$2.4M 0.03% 167
2020
Q4 		$2.87M Sell
17,033
-11,151
-40% -$1.66M 0.1% 80
2020
Q3 		$4.16M Sell
28,184
-171,255
-86% -$26.5M 0.14% 67
2020
Q2 		$32.7M Buy
199,439
+19,547
+11% +$3M 1.1% 32
2020
Q1 		$24.9M Buy
+179,892
New +$24.7M 0.93% 36
2019
Q3 		$34.9M Buy
311,647
+234
+0.1% +$26.1K 0.96% 38
2019
Q2 		$34.5M Sell
311,413
-176,336
-36% -$20.8M 0.92% 43
2019
Q1 		$63.3M Sell
487,749
-92,516
-16% -$11.2M 1.69% 17
2018
Q4 		$67.1M Sell
580,265
-88,288
-13% -$9.86M 1.69% 15
2018
Q3 		$71.7M Sell
668,553
-84,739
-11% -$8.47M 1.52% 10
2018
Q2 		$64.3M Buy
+753,292
New +$61.9M 1.27% 17

Other funds holding LLY

PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Unigestion Holding's LLY Position: Q1 2025 in Review

Unigestion Holding increased its Eli Lilly (LLY) stake by 158% in Q1 2025, buying an estimated $2.05M and bringing the position to 4,012 shares worth $3.31M. The position accounts for 0.19% of the portfolio, ranked #95.

Unigestion Holding first reported a position in LLY in Q2 2018 and has held it in 27 quarters since. The position peaked at $71.7M in Q3 2018. 3,920 funds tracked by Wall St. Rank hold LLY as of Q1 2025.

  • Unigestion Holding held 4,012 shares of Eli Lilly worth $3.31M as of Q1 2025.
  • Unigestion Holding bought 2,459 Eli Lilly shares in Q1 2025, an estimated $2.05M.
  • Eli Lilly made up 0.19% of Unigestion Holding's portfolio in Q1 2025, its #95 holding.
  • Unigestion Holding first reported a position in Eli Lilly in Q2 2018 and has held it in 27 quarters since.
  • Unigestion Holding's Eli Lilly position peaked at $71.7M in Q3 2018.
  • 3,920 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2025.

Based on Unigestion Holding's 13F filing for Q1 2025, filed 10 Apr 2025.